Events and Presentations

Inhibrx Announces ozekibart (INBRX-109) Phase 2 results in Chondrosarcoma and Provides Update on CRC and Ewing Cohorts
 Thursday, October 23, 2025
 1:30pm - 2:30pm PDT
 Listen to the Webcast
Back To Top